Scandinavian Medical Solutions A/S
CSE:SMSMED
Relative Value
The Relative Value of one SMSMED stock under the Base Case scenario is 8.02 DKK. Compared to the current market price of 3.3 DKK, Scandinavian Medical Solutions A/S is Undervalued by 59%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SMSMED Competitors Multiples
Scandinavian Medical Solutions A/S Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
S
|
Scandinavian Medical Solutions A/S
CSE:SMSMED
|
91.4m DKK | 0.4 | 3 514.1 | 13.9 | 81.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
114.9B USD | 0.3 | 26.5 | 18.6 | 20.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD | 0.2 | 42.1 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.1B USD | 0.2 | 42 | 14.7 | 18.7 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.8B USD | 0.2 | 30.6 | 14.8 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62B CNY | 1.4 | 16.8 | 12.9 | 12.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 22.3 | 11 | 15.4 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |